EN
HI
Summary
As of 31 Aug, 2026, Strides Pharma Science stock price is ₹1013.7. During the trading session, the stock has moved between an intraday low of ₹1006.90 and an intraday high of ₹1038.10. Over the last 52 weeks, Strides Pharma Science has traded between ₹768.65 and ₹1231.00.
The stock has recorded a trading volume of 1,85,695 shares, with a market capitalization of ₹92172714. Its Average Traded Price (ATP) is ₹1021.26, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1013.70.
Strides Pharma Science has an upper circuit limit of ₹1223.80 and a lower circuit limit of ₹816.00. The total value traded stands at ₹18.96 CR, and the delivery percentage for the day is 63.52%.
The stock is currently traded with a market lot size of 1. Strides Pharma Science also offers a dividend yield of 0.49%.
Strides Pharma Science share price chart
Strides Pharma Science Share Key Metrics
Volume
1.86 L
Market Cap
9400.70 CR
LTQ@LTP
1@1013.70
ATP
1021.26
Var Margin
19.39 %
Circuit Range
816-1223.8
Delivery %
63.52 %
Value
18.96 CR
ASM/GSM
No
Market Lot
1
Strides Pharma Science Fundamentals
P/E Ratio
15.33
P/B Ratio
2.87
Div. Yield
0.49
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Strides Pharma Science Resistance and Support
Pivot 1009.5
Resistance
First Resistance
1036.9
Second Resistance
1053.9
Third Resistance
1081.3
Support
First Support
992.5
Second Support
965.1
Third Support
948.1
Strides Pharma Science Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 31 2026 | 1029 | 1013.7 | -0.61% | 1038.1 | 1006.9 |
| Fri Aug 28 2026 | 984 | 1019.9 | 3.75% | 1026.5 | 982.09 |
| Thu Aug 27 2026 | 982.9 | 983 | 0.01% | 994.4 | 978.9 |
Strides Pharma Science Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
| 2024-10-24 | Quarterly Results |
| 2024-07-29 | Quarterly Results |
Strides Pharma Science News
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides Pharma Science received a USFDA Establishment Inspection Report (EIR) for its flagship Bengaluru manufacturing facility. The inspection, which had five Form 483 observations, is now successfully concluded with a Voluntary Action Indicated (VAI) classification, strengthening the company's regulatory standing.
Aug 19 2026 19:37:37
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Strides Pharma Science held its Q1 FY27 earnings call, reporting strong performance with a 56.7% YoY increase in reported PAT to Rs.165.5 crore and 17% YoY growth in Ex-US revenue. The company also announced a CARE Ratings upgrade to A+; Stable for Long-Term Bank Facilities.
Aug 03 2026 17:24:32
Strides Pharma Science Management
| Name | Position |
|---|---|
| Arun Kumar | Chairman |
| Kausalya Santhanam | Non Executive Independent Director |
Strides Pharma Science Similar Stocks
Sanofi Consumer Healthcare India Ltd.
4160.40
-53.30 (1.26%)
Blue Jet Healthcare Ltd.
577.00
-0.65 (0.11%)
Healthcare Global Enterprises Ltd.
707.20
10.90 (1.57%)
Suven Life Sciences Ltd.
383.40
18.45 (5.06%)
Jupiter Life Line Hospitals Ltd.
304.20
2.80 (0.93%)
Thyrocare Technologies Ltd.
594.30
9.95 (1.70%)
Yatharth Hospital & Trauma Care Services Ltd.
993.85
26.45 (2.73%)
Procter & Gamble Health Ltd.
5730.00
59.50 (1.05%)
Aarti Pharmalabs Ltd.
858.80
18.10 (2.15%)
Sanofi India Ltd.
3138.00
-43.60 (1.37%)
Strides Pharma Science FAQs
The Buying Price of Strides Pharma Science share is 1013.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Strides Pharma Science stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Strides Pharma Science, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Strides Pharma Science shares is 15.33. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Strides Pharma Science shares is 2.87. Useful to assess the stock's value relative to its book value.
To assess Strides Pharma Science’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Strides Pharma Science is 9400.70 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Strides Pharma Science share price is 1231.00 & 768.65. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Strides Pharma Science belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
